Market Tracker

01/26 7:09am ET

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

23.79
Data as of Jan 23
 +0.12 / +0.51%
Today’s Change
11.34
Today|||52-Week Range
39.80
-38.29%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close23.67
Today’s open23.12
Day’s range-- - --
Volume24,278
Average volume (3 months)30,028
Market cap$343.0M
Dividend yield2.81%
Data as of 01/23/2015

Growth & Valuation

Earnings growth (last year)-108.57%
Earnings growth (this year)+88.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-81.80%
P/E ratioNM
Price/Sales36.10
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...-0.28-1.41%
PTXPernix Therapeutics ...-0.06-0.69%
SRNESorrento Therapeutic...-0.02-0.20%
CCXIChemoCentryx Inc+0.15+1.80%
Data as of 01/23/2015

Financials

Last reporting dateNovember 13, 2014
EPS forecast (this quarter)-$10.38
Annual revenue (last year)$1.7M
Annual profit (last year)-$27.4M
Net profit margin-1,571.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts